Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S. The financial sector led markets higher. Netflix (NFLX) shares rose Monday as the streaming company is expected to report earnings of 37 cents a share on revenue of $2.64 billion after the closing bell. Eli Lilly (LLY) shares dropped, while Incyte's (INCY) shares tumbled after the company's joint application for the once-daily oral medication for the treatment of moderate-to-severe rheumatoid arthritis, was rejected by the Food and Drug Administration. Finally, OncoMed Pharmaceuticals (OMED) dropped over 17% after the bio-pharmaceutical company said the phase 2 trial of its drug for small cell lung cancer, didn't meet its primary or secondary endpoints.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.